WO2009042402A3 - Composition and method for treating rosacea - Google Patents

Composition and method for treating rosacea Download PDF

Info

Publication number
WO2009042402A3
WO2009042402A3 PCT/US2008/075834 US2008075834W WO2009042402A3 WO 2009042402 A3 WO2009042402 A3 WO 2009042402A3 US 2008075834 W US2008075834 W US 2008075834W WO 2009042402 A3 WO2009042402 A3 WO 2009042402A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
skin
rosacea
treating rosacea
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/075834
Other languages
French (fr)
Other versions
WO2009042402A2 (en
Inventor
Nava Dayan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lipo Chemicals Inc
Original Assignee
Lipo Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipo Chemicals Inc filed Critical Lipo Chemicals Inc
Publication of WO2009042402A2 publication Critical patent/WO2009042402A2/en
Publication of WO2009042402A3 publication Critical patent/WO2009042402A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

A composition for the treatment of skin exhibiting the symptoms of rosacea, and a method of treating the skin of an individual suffering from rosacea, are disclosed. The composition comprises a hydroxycinnamic acid and/or a methoxycinnamic acid and a suitable carrier for topical application of the composition to mammalian skin. The composition and method reduces skin redness, flushing, pimples, pustules, and skin bumps associated with rosacea.
PCT/US2008/075834 2007-09-27 2008-09-10 Composition and method for treating rosacea Ceased WO2009042402A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97555807P 2007-09-27 2007-09-27
US60/975,558 2007-09-27

Publications (2)

Publication Number Publication Date
WO2009042402A2 WO2009042402A2 (en) 2009-04-02
WO2009042402A3 true WO2009042402A3 (en) 2009-11-26

Family

ID=40020147

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/075834 Ceased WO2009042402A2 (en) 2007-09-27 2008-09-10 Composition and method for treating rosacea

Country Status (1)

Country Link
WO (1) WO2009042402A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100291201A1 (en) * 2009-05-14 2010-11-18 Cerovene, Inc. Coated pharmaceutical capsule dosage form
EP2377556A1 (en) * 2010-04-14 2011-10-19 Cognis IP Management GmbH A compound
US12318406B2 (en) * 2013-03-15 2025-06-03 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11318089B2 (en) 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
US8652516B1 (en) * 2013-03-15 2014-02-18 Cerovene, Inc. Doxycycline formulations, and methods of treating rosacea
US10398733B2 (en) 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
GB2619517A (en) * 2022-06-07 2023-12-13 Dyson Operations Pte Ltd Compositions for sebum control

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
EP1637143A1 (en) * 2004-09-10 2006-03-22 Stiefel Laboratories, Inc. Sulfacetamide formulations further containing a sunscreen for treatment of rosacea
WO2006060470A1 (en) * 2004-12-02 2006-06-08 Piotr Chomczynski Antioxidant dietary supplement compositions and methods for maintaining healthy skin
WO2006078399A2 (en) * 2005-01-14 2006-07-27 Lipo Chemicals, Inc. Composition and method for treating hyperpigmented skin
KR20070093889A (en) * 2006-03-14 2007-09-19 바이오스펙트럼 주식회사 Rosacia prophylactic or therapeutic external skin composition comprising rosemarine acid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972993A (en) * 1998-03-20 1999-10-26 Avon Products, Inc. Composition and method for treating rosacea and sensitive skin with free radical scavengers
EP1637143A1 (en) * 2004-09-10 2006-03-22 Stiefel Laboratories, Inc. Sulfacetamide formulations further containing a sunscreen for treatment of rosacea
WO2006060470A1 (en) * 2004-12-02 2006-06-08 Piotr Chomczynski Antioxidant dietary supplement compositions and methods for maintaining healthy skin
WO2006078399A2 (en) * 2005-01-14 2006-07-27 Lipo Chemicals, Inc. Composition and method for treating hyperpigmented skin
KR20070093889A (en) * 2006-03-14 2007-09-19 바이오스펙트럼 주식회사 Rosacia prophylactic or therapeutic external skin composition comprising rosemarine acid

Also Published As

Publication number Publication date
WO2009042402A2 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
WO2009042402A3 (en) Composition and method for treating rosacea
WO2008124085A3 (en) Methods of using combinations of mek and jak-2 inhibitors
WO2012002760A3 (en) Method for treating and diagnosing cancer by using cell-derived microvesicles
WO2008057930A3 (en) Methods of treating neuropathic pain with retinoic acid receptor agonists
AU2011201462B2 (en) Method of Administering Pirfenidone Therapy
WO2009032321A3 (en) A method for treating diabetes
WO2007087468A3 (en) Adiponectin for treatment of various disorders
WO2006093348A3 (en) Method and composition for treating peripheral vascular diseases
WO2007100895A3 (en) Cancer treatment with gamma-secretase inhibitors
WO2010025321A3 (en) Method for treating multiple sclerosis patients with anti-il2r antibodies
WO2008079363A3 (en) Substituted tetracycline compounds for treatment of inflammatory skin disorders
WO2010107807A3 (en) Compounds for treating inflammation and pain
WO2010003568A8 (en) Topical composition for the treatment of actinic keratosis
WO2010097788A3 (en) Visfatin therapeutic agents for the treatment of acne and other conditions
WO2011109262A3 (en) Cancer diagnosis and imaging
WO2012050831A3 (en) Combination treatment for dermatological conditions
WO2012047645A3 (en) Combination treatment for rosacea
WO2011156811A3 (en) Compounds for treatment of bovine mastitis
WO2009124294A3 (en) Pharmaceutical compositions for binding sphingosine-1-phosphate
WO2009127414A3 (en) Inhibition of angiogenesis and tumor metastasis
WO2009095877A3 (en) Method of predicting pain medication efficacy
WO2012037008A3 (en) Therapy for mll-rearranged leukemia
WO2011031890A3 (en) Cancer stem cell-targeted and drug resistant cancer therapy
WO2008104883A8 (en) Methods for the treatment of anal incontinence
WO2013037985A8 (en) Pharmaceutical combinations including anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08833395

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08833395

Country of ref document: EP

Kind code of ref document: A2